DR Congo

Targeting the Bundibugyo Strain with Obeldesivir The World Health Organization (WHO) has launched the EBO-PEP clinical trial, the first to test the antiviral drug obeldesivir as a post-exposure treatment for …

Remdesivir, an antiviral medication originally developed for Ebola, remains a standard treatment for hospitalized patients with COVID-19. According to the National Institutes of Health (NIH), the drug works by inhibiting …

The National Institutes of Health (NIH) is conducting the ACTIV-3 clinical trial to evaluate the safety and efficacy of the monoclonal antibody MBP134 alongside the antiviral drug remdesivir in hospitalized …

France’s Ebola Situation: No Confirmed Cases, Public Health Measures in Place France’s Ebola Situation: No Confirmed Cases, Public Health Measures in Place As of the latest data from the World …

Public Health Update: Understanding Ebola Virus Risks and International Protocols The Ebola virus is a rare but severe zoonotic disease characterized by high mortality rates, typically requiring strict international monitoring …

Public Health Emergency Declared: Ebola Outbreak in DRC and Uganda The World Health Organization (WHO) has officially determined that the current Ebola disease outbreak caused by the Bundibugyo virus in …

Ebola Outbreak in Eastern DR Congo: A Growing Public Health Crisis The Democratic Republic of Congo (DRC) is currently grappling with a challenging Ebola outbreak in its eastern provinces. The …

Zimbabwe Bans Raw Mineral Exports, Including Lithium, to Boost Local Processing Zimbabwe has suspended exports of all raw minerals, including lithium concentrates, with immediate effect, as the government seeks to …